How Has the Angina Market Evolved Historically and What is its Current Size?
The angina market has seen considerable growth due to a variety of factors.
• The angina market has grown strongly in recent years. It will increase from $10.71 billion in 2024 to $11.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%.
This growth is linked to the increased prevalence of coronary heart disease, greater use of vasodilators, higher rates of myocardial ischemia, improved diagnostic capabilities, and the expanded use of imaging techniques.
What Does Future Hold for The Angina Market By 2029?
The angina market is expected to maintain its strong growth trajectory in upcoming years.
• The angina market is projected to grow strongly, reaching $14.44 billion by 2029 with a CAGR of 6.1%.
The growth is driven by the rising prevalence of chronic angina pectoris, drug approvals, clinical research, greater awareness of cardiovascular health, and rising medication demand. Key trends include technological advancements in early diagnosis, angioplasty and stenting innovations, gene therapy approaches, demand for coronary stents, and advancements in coronary artery disease treatments.
What Are The Primary Growth Drivers In The Angina Market?
The growing prevalence of coronary artery diseases is expected to stimulate the growth of the angina market. Coronary artery disease (CAD) involves the narrowing of the coronary arteries, leading to heart-related complications. The rise in CAD is linked to lifestyle changes, genetics, and environmental factors. Angina is a critical indicator of CAD and aids in diagnosis, treatment planning, and public health strategies. For example, in January 2023, the American Heart Association reported that CAD cases in the US increased from 18.2 million in 2021 to 19.3 million in 2022. The rising incidence of CAD is driving the angina market.
What Is The Segmentation Of The Global Angina Market?
The angina market covered in this report is segmented –
1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications
Subsegments:
1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease
Pre-Book The Angina Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Angina Market Landscape?
Companies in the angina market are developing innovative medications like metoprolol tartrate tablets to offer more effective treatments for coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are used to treat cardiovascular issues, including angina and hypertension. In April 2023, Zydus, an India-based pharmaceutical company, received US-FDA approval to market its generic version of Metoprolol Tartrate Tablets in 25 mg, 50 mg, and 100 mg strengths. Metoprolol, a beta blocker, is commonly prescribed to treat cardiovascular conditions and improve survival rates after a heart attack.
Who Are the Key Players In The Angina Market?
Major companies operating in the angina market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Merck & Co Inc.
• Bayer AG
• Sanofi S.A.
• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott laboratories
• GlaxoSmithKline Plc
• Eli Lilly and Company
• Gilead Sciences Inc.
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Troikaa Pharmaceuticals Ltd
• Amgen Inc.
• Dr. Reddy's Laboratories
• ViroMed Co. Ltd.
• Lee’s Pharmaceutical Holdings
• Kuhnil Pharmaceutical
• LegoChem Biosciences
• Axus Cardium Pharmaceuticals
• Juventas Therapeutics
• Milestone Pharmaceuticals
What Are The Regional Insights Into The Angina Market?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
